메뉴 건너뛰기




Volumn 18, Issue 4, 2011, Pages 225-229

Therapeutic drug monitoring in the treatment of active tuberculosis

Author keywords

Antituberculosis drugs; Pharmacokinetics; Pharmacology; Therapeutic drug monitoring; Tuberculosis treatment

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN;

EID: 84860441549     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/307150     Document Type: Article
Times cited : (75)

References (20)
  • 1
    • 70349638608 scopus 로고    scopus 로고
    • World Health Organization. 4th edn. Geneva: World Health Organization; Report No.: WHO/HTM/TB/2009.420
    • World Health Organization. Treatment of Tuberculosis Guidelines, 4th edn. Geneva: World Health Organization; 2009. Report No.: WHO/HTM/TB/2009.420.
    • (2009) Treatment of Tuberculosis Guidelines
  • 2
    • 0003573158 scopus 로고    scopus 로고
    • 6th edn. Toronto: Canadian Lung Association, Public Health Agency of Canada, Tuberculosis Prevention and Control
    • Long RL, Ellis E. Canadian Tuberculosis Standards, 6th edn. Toronto: Canadian Lung Association, Public Health Agency of Canada, Tuberculosis Prevention and Control, 2007.
    • (2007) Canadian Tuberculosis Standards
    • Long, R.L.1    Ellis, E.2
  • 3
    • 0037441632 scopus 로고    scopus 로고
    • Treatment of tuberculosis
    • American Thoracic Society, Infectious Diseases Society of America, Centres for Disease Control
    • American Thoracic Society, Infectious Diseases Society of America, Centres for Disease Control. Treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62.
    • (2003) Am J Respir Crit Care Med , vol.167 , pp. 603-662
  • 4
    • 70349634546 scopus 로고    scopus 로고
    • Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: A systematic review and meta-analysis
    • Menzies D, Benedetti A, Paydar A, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: A systematic review and meta-analysis. PLOS Med 2009;6:e1000146.
    • (2009) PLOS Med , vol.6
    • Menzies, D.1    Benedetti, A.2    Paydar, A.3
  • 5
    • 0036033914 scopus 로고    scopus 로고
    • Therapeutic drug monitoring in the treatment of tuberculosis
    • Peloquin C. Therapeutic drug monitoring in the treatment of tuberculosis. Drugs 2002;62:2169-83. (Pubitemid 35252827)
    • (2002) Drugs , vol.62 , Issue.15 , pp. 2169-2183
    • Peloquin, C.A.1
  • 8
    • 0035166747 scopus 로고    scopus 로고
    • Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy
    • DOI 10.1378/chest.120.5.1520
    • Mehta J, Shantaveerapa H, Byrd R, Morton S, et al. Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy. Chest 2001;120:1520-4. (Pubitemid 33078467)
    • (2001) Chest , vol.120 , Issue.5 , pp. 1520-1524
    • Mehta, J.B.1    Shantaveerapa, H.2    Byrd Jr., R.P.3    Morton, S.E.4    Fountain, F.5    Roy, T.M.6
  • 11
    • 51449107422 scopus 로고    scopus 로고
    • Department of Health and Human Services (Accessed on July 4, 2011)
    • Department of Health and Human Services/Centers for Disease Control and Prevention. Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis, 2007. 〈http://www.cdc.gov/tb/TB-HIV-Drugs/default.htm〉 (Accessed on July 4, 2011).
    • (2007) Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
  • 12
    • 72849124759 scopus 로고    scopus 로고
    • Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis
    • Boulanger C, Hollender E, Farrell K, et al. Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis. Clin Infect Dis 2009;49:1305-11.
    • (2009) Clin Infect Dis , vol.49 , pp. 1305-1311
    • Boulanger, C.1    Hollender, E.2    Farrell, K.3
  • 13
    • 0021711632 scopus 로고
    • Clinical pharmacokinetics of the antituberculosis drugs
    • Holdiness MR. Clinical pharmacokinetics of the antituberculosis drugs. Clin Pharmacokinet 1984;9:511-44. (Pubitemid 15211649)
    • (1984) Clinical Pharmacokinetics , vol.9 , Issue.6 , pp. 511-544
    • Holdiness, M.R.1
  • 15
    • 66949172863 scopus 로고    scopus 로고
    • Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana
    • Chideya S, Winston C, Peloquin CA, Bradford WZ, et al. Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis 2009;48:1685-94.
    • (2009) Clin Infect Dis , vol.48 , pp. 1685-1694
    • Chideya, S.1    Winston, C.2    Peloquin, C.A.3    Bradford, W.Z.4
  • 16
    • 0038796548 scopus 로고    scopus 로고
    • Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid
    • DOI 10.1046/j.1445-5994.2003.00390.x
    • Ray J, Gardiner I, Marriott D. Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid. Internal Med J 2003;33:229-34. (Pubitemid 36718380)
    • (2003) Internal Medicine Journal , vol.33 , Issue.5-6 , pp. 229-234
    • Ray, J.1    Gardiner, I.2    Marriott, D.3
  • 17
    • 20244364939 scopus 로고    scopus 로고
    • Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection
    • Sahai J, Gallicano K, Swick L, et al. Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection. Ann Intern Med 1997;127:289.
    • (1997) Ann Intern Med , vol.127 , pp. 289
    • Sahai, J.1    Gallicano, K.2    Swick, L.3
  • 18
    • 66249133047 scopus 로고    scopus 로고
    • Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection
    • Holland DP, Hamilton CD, Weintrob AC, et al. Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection. Pharmacotherapy 2009;29:503-10.
    • (2009) Pharmacotherapy , vol.29 , pp. 503-510
    • Holland, D.P.1    Hamilton, C.D.2    Weintrob, A.C.3
  • 20
    • 65649136872 scopus 로고    scopus 로고
    • Tuberculosis pharmacotherapy: Strategies to optimize patient care
    • Mitnick CD, McGee B, Peloquin CA. Tuberculosis pharmacotherapy: Strategies to optimize patient care. Expert Opin Pharmacother 2009;10:381-401.
    • (2009) Expert Opin Pharmacother , vol.10 , pp. 381-401
    • Mitnick, C.D.1    McGee, B.2    Peloquin, C.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.